AG
RCEL icon

Advisor Group’s Avita Medical RCEL Stock Holding History

Advisor Group’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$8K Buy
+173
New +$7.19K ﹤0.01% 4467

Other funds holding RCEL

BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.8B AUM 19.11% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Advisor Group's RCEL Position: Q4 2019 in Review

Advisor Group opened a new position in Avita Medical (RCEL) in Q4 2019: 173 shares worth $8K. The stake represents ﹤0.01% of the portfolio and ranks #4467 among its holdings.

31 funds tracked by Wall St. Rank hold RCEL as of Q4 2019.

  • Advisor Group held 173 shares of Avita Medical worth $8K as of Q4 2019.
  • Avita Medical was a new Advisor Group position in Q4 2019.
  • Avita Medical made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4467 holding.
  • 31 funds tracked by Wall St. Rank held Avita Medical as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.